Exenatide

dipeptidyl peptidase 4 ; Homo sapiens







15 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 30663560 Endothelium as a Therapeutic Target in Diabetes Mellitus: From Basic Mechanisms to Clinical Practice. 2020 1
2 30554037 Exenatide modulates expression of metalloproteinases and their tissue inhibitors in TNF-α stimulated human retinal pigment epithelial cells. 2019 Feb 1
3 27030119 [Incretin therapies and multifactorial clinical approach to cardiometabolic patients]. 2016 Mar 1
4 26788106 Medicinal Plants Qua Glucagon-Like Peptide-1 Secretagogue via Intestinal Nutrient Sensors. 2015 2
5 22382611 Incretin-based therapies in clinical practice: from efficacy to effectiveness. Focus on liraglutide. 2012 Mar 2
6 21871831 Beyond glucose lowering: glucagon-like peptide-1 receptor agonists, body weight and the cardiovascular system. 2011 Dec 2
7 20380648 Diabetes and obesity: therapeutic targeting and risk reduction - a complex interplay. 2010 Apr 1
8 19182763 Incretin mimetics and DPP-4 inhibitors: new approach to treatment of type 2 diabetes mellitus. 2009 Jan 1
9 19952298 Role of the incretin pathway in the pathogenesis of type 2 diabetes mellitus. 2009 Dec 1
10 18020966 The entero-insular axis: implications for human metabolism. 2008 1
11 18201204 Effects of exendin-4 on islets from type 2 diabetes patients. 2008 Jun 1
12 18402245 Glucagon-like peptide 1 based therapy for type 2 diabetes. 2008 Feb 1
13 18630617 [Exenatid and its position as antidiabetic drug in the treatment of type 2 diabetes mellitus]. 2008 Apr 1
14 27056542 Incretin-based Therapies for Type 2 Diabetes. 2008 1
15 17263764 Incretins and other peptides in the treatment of diabetes. 2007 Mar 2